UK markets closed

Brainstorm Cell Therapeutics Inc. (BCLI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5320+0.0177 (+3.44%)
At close: 04:00PM EDT
0.5300 -0.00 (-0.38%)
After hours: 07:42PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
11,499
13,956
15,235
22,329
Selling general and administrative
10,051
10,866
9,304
9,355
Total operating expenses
21,550
24,822
24,539
31,684
Operating income or loss
-21,550
-24,822
-24,539
-31,684
Income before tax
-16,632
-24,277
-24,457
-31,811
Income from continuing operations
-16,632
-24,277
-24,457
-31,811
Net income
-16,632
-24,277
-24,457
-31,811
Net income available to common shareholders
-16,632
-24,277
-24,457
-31,811
Basic EPS
-0.42
-0.66
-0.68
-1.07
Diluted EPS
-0.42
-0.66
-0.68
-1.07
Basic average shares
39,346
36,509
36,182
29,848
Diluted average shares
39,346
36,509
36,182
29,848